Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Acute Symptomatic Deep-Vein Thrombosis (Einstein-DVT)
NCT00440193Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 34
01
Overview
A Phase 3 trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by Bayer. Started Mar 2007; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00440193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440193.